Nurix Therapeutics
NRIX
NRIX
195 hedge funds and large institutions have $1.81B invested in Nurix Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 67 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 182 → 195 (+13)
16% less capital invested
Capital invested by funds: $2.15B → $1.81B (-$338M)
34.35% less ownership
Funds ownership: 147.52% → 113.17% (-34%)
Holders
195
Holding in Top 10
5
Calls
$3.95M
Puts
$237K
Top Buyers
| 1 | +$30M | |
| 2 | +$26.2M | |
| 3 | +$21.7M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$14.8M |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$9.33M |
Top Sellers
| 1 | -$45.8M | |
| 2 | -$13.2M | |
| 3 | -$12.9M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$12.3M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$11.5M |
